Dow Jones Industrial Average Q3 2015 Performance Report Card

The Dow Jones Industrial Average ended September at 16,284.70 – down 1,538.37 points year to date for a -8.63% return. Q3 2015 was the worst calendar quarter since Q3 2011. Leader & Laggard – Nike (NKE) was the biggest contributor during Q3; Goldman Sachs (GS) was the biggest detractor. Industry Performance – the Consumer Goods Read more […]

SPIVA Global

In recent years, passive management has had an increasingly strong foothold, with a sharp rise in assets under management (AUM). According to PricewaterhouseCoopers Asset Management’s 2020 report, the AUM of global passive investments stood at USD 7.3 trillion as of 2012, and they are expected to grow to USD 22.7 trillion by 2020. The active Read more […]

Commodities Post 3rd Worst Q3 Since 1970

The S&P GSCI Total Return lost 19.3% in the third quarter of 2015. This was the 5th worst quarter and the 3rd worst 3rd quarter for commodities in history since 1970. Historically worse quarters were: Q4 2008 (-47.0%,) Q3 2008 (-28.6%,) Q4 2014 (-27.7%,) and Q3 1976 (-20.2%.) In total, there have been 183 quarters where 67 were negative Read more […]

Catalysts for ETF Market Growth in Hong Kong and China

The Asia-Pacific region is the third-largest ETF market in the world, after the U.S. and Europe. Despite the fact that the ETFs listed in the Asia-Pacific region represent less than 10% of global ETF assets, the region’s asset growth rate has outpaced the two former leaders and is now ranked at the top. The Asia-Pacific Read more […]

The Tale of Dividend in India

Dividend yield is an important source of total return from an investment in equities. The other source is capital gains. While capital gains tend to be volatile and depend on the stock price movement in the market, dividend income tends to remain stable and depends on the dividend distribution policy of the company. The dividend Read more […]

Daraprim Price Increase–The Effect on Generic Drug Costs

The week of Sept. 21, 2015, saw a flurry of stories about the escalating cost of drugs in the U.S. marketplace. These stories were all initiated by Turing Pharmaceuticals buyout of the drug Daraprim (NY Times Story) and the decision to increase the price per tablet from USD 13.50 to USD 750.00. Turing’s stated reason Read more […]

Canada: Bonds Recover as Central Bank Leaves Rates Unchanged

The Bank of Canada left its key interest rate unchanged at 0.5% last Wednesday, Sept. 9, 2015.  The message from the central bank was that it could be “considerable time” before there is significant recovery from the collapse of oil prices that pushed the economy into a technical recession.  The last rate cut was back Read more […]

Speculating About the Fed’s Timing

Little new data, lots of chatter from Wall Street and no clear signals about what the Fed might do at next week’s FOMC meeting. The announcement, either no change or a rate increase, is expected on Thursday afternoon September 17th around 2 PM Washington DC time. Those looking for some hint of what this might Read more […]

Rising Momentum of Islamic Finance in China

In the Islamic Finance News Report “China- the time is now”, it highlighted a few initiatives that demonstrated the rising momentum of Islamic finance in China, see examples below, Chinese brokerage Southwest Securities forged a partnership with Qatar International Islamic Bank to pave the way for Islamic finance transactions in the country. The Qatari bank Read more […]

Global Infrastructure Investments

Once every four years, America’s civil engineers provide a comprehensive assessment of the nation’s major infrastructure categories. The latest report card has a poor cumulative GPA for infrastructure of D+, with rail and bridges each earning a C+. While Congress continues to debate whether, and how, to fund the projects to improve the quality of Read more […]